AbbVie
ABBV
3,906 hedge funds and large institutions have $294B invested in AbbVie in 2025 Q3 according to their latest regulatory filings, with 292 funds opening new positions, 1,658 increasing their positions, 1,471 reducing their positions, and 103 closing their positions.
183% more first-time investments, than exits
New positions opened: 292 | Existing positions closed: 103
44% more funds holding in top 10
Funds holding in top 10: 150 → 216 (+66)
22% more capital invested
Capital invested by funds: $242B → $294B (+$52.5B)
16% more call options, than puts
Call options by funds: $4.29B | Put options by funds: $3.71B
13% more repeat investments, than reductions
Existing positions increased: 1,658 | Existing positions reduced: 1,471
3% more funds holding
Funds holding: 3,782 → 3,906 (+124)
1.13% less ownership
Funds ownership: 73.11% → 71.98% (-1.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$1.76B |
| 2 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$361M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
+$358M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$314M |
| 5 |
Amundi
Paris,
France
|
+$288M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
-$600M |
| 2 |
BC
Broadwater Capital
Boston,
Massachusetts
|
-$497M |
| 3 |
UBS AM
Chicago,
Illinois
|
-$412M |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$373M |
| 5 |
BlackRock
New York
|
-$301M |
ABBV Hedge Fund Activity: Q3 2025 in Review
3,906 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in AbbVie (ABBV) for Q3 2025, worth a combined $294B — up 22% from $242B a quarter earlier.
Buyers outnumbered sellers: 292 funds opened new ABBV positions and 103 closed out — a net gain of 189 holders — while 1,658 added to existing stakes and 1,471 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $1.76B. The largest seller was Capital International Investors, cutting an estimated $600M.
- 3,906 institutional investors held AbbVie (ABBV) as of Q3 2025, up from 3,782 in Q2 2025.
- Funds reported $294B of AbbVie stock for Q3 2025, up 22% quarter-over-quarter.
- 292 funds opened new AbbVie positions in Q3 2025 and 103 closed out, a net change of +189 holders.
- The largest AbbVie buyer in Q3 2025 was Wellington Management Group, an estimated $1.76B added.
- The largest AbbVie seller in Q3 2025 was Capital International Investors, an estimated $600M sold.
Based on aggregated 13F filings for Q3 2025.